Two Sigma Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,200
Closed -$208K – 2392
2024
Q3
$208K Buy
5,200
+500
+11% +$23.3K ﹤0.01% 2115
2024
Q2
$224K Sell
4,700
-1,100
-19% -$45.1K ﹤0.01% 2259
2024
Q1
$251K Buy
5,800
+1,100
+23% +$52.4K ﹤0.01% 2123
2023
Q4
$238K Sell
4,700
-2,400
-34% -$115K ﹤0.01% 2226
2023
Q3
$322K Sell
7,100
-300
-4% -$12.4K ﹤0.01% 1892
2023
Q2
$304K Buy
+7,400
New +$284K ﹤0.01% 1860
2022
Q4
– Sell
-5,300
Closed -$234K – 2904
2022
Q3
$234K Buy
+5,300
New +$223K 0.01% 1804
2022
Q2
– Sell
-6,900
Closed -$256K – 2526
2022
Q1
$256K Buy
+6,900
New +$226K 0.01% 1540
2020
Q1
– Sell
-4,800
Closed -$290K – 1818
2019
Q4
$290K Buy
+4,800
New +$286K ﹤0.01% 1812
2018
Q4
– Sell
-14,500
Closed -$748K – 2469
2018
Q3
$748K Buy
14,500
+5,700
+65% +$268K ﹤0.01% 1173
2018
Q2
$367K Sell
8,800
-300
-3% -$13.3K ﹤0.01% 1939
2018
Q1
$401K Buy
+9,100
New +$462K ﹤0.01% 1814

Other funds holding IONS

Two Sigma Securities's IONS Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 9,581 shares worth $428K. The stake represents 0.03% of the portfolio and ranks #694 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in IONS as recently as Q4 2025.

Two Sigma Securities first reported a position in IONS in Q2 2017 and has held it in 14 quarters since. The position peaked at $3.82M in Q2 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Two Sigma Securities held 9,581 shares of Ionis Pharmaceuticals worth $428K as of Q3 2026.
  • Ionis Pharmaceuticals was a new Two Sigma Securities position in Q3 2026.
  • Ionis Pharmaceuticals made up 0.03% of Two Sigma Securities's portfolio in Q3 2026, its #694 holding.
  • Two Sigma Securities first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 14 quarters since.
  • Two Sigma Securities's Ionis Pharmaceuticals position peaked at $3.82M in Q2 2024.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.